Cargando…

Artificial intelligence in drug development: clinical pharmacologist perspective

Detalles Bibliográficos
Autor principal: Jang, In-Jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989241/
https://www.ncbi.nlm.nih.gov/pubmed/32055587
http://dx.doi.org/10.12793/tcp.2019.27.3.87
_version_ 1783492365766361088
author Jang, In-Jin
author_facet Jang, In-Jin
author_sort Jang, In-Jin
collection PubMed
description
format Online
Article
Text
id pubmed-6989241
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Korean Society for Clinical Pharmacology and Therapeutics
record_format MEDLINE/PubMed
spelling pubmed-69892412020-02-13 Artificial intelligence in drug development: clinical pharmacologist perspective Jang, In-Jin Transl Clin Pharmacol Commentary Korean Society for Clinical Pharmacology and Therapeutics 2019-09 2019-09-30 /pmc/articles/PMC6989241/ /pubmed/32055587 http://dx.doi.org/10.12793/tcp.2019.27.3.87 Text en Copyright © 2019 In-Jin Jang http://creativecommons.org/licenses/by-nc/3.0/ It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).
spellingShingle Commentary
Jang, In-Jin
Artificial intelligence in drug development: clinical pharmacologist perspective
title Artificial intelligence in drug development: clinical pharmacologist perspective
title_full Artificial intelligence in drug development: clinical pharmacologist perspective
title_fullStr Artificial intelligence in drug development: clinical pharmacologist perspective
title_full_unstemmed Artificial intelligence in drug development: clinical pharmacologist perspective
title_short Artificial intelligence in drug development: clinical pharmacologist perspective
title_sort artificial intelligence in drug development: clinical pharmacologist perspective
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989241/
https://www.ncbi.nlm.nih.gov/pubmed/32055587
http://dx.doi.org/10.12793/tcp.2019.27.3.87
work_keys_str_mv AT janginjin artificialintelligenceindrugdevelopmentclinicalpharmacologistperspective